Back

PCSK9 inhibitors: more volumes to come?

27 August 2017 (19:10 - 19:15)
Organised by:
Congress Presentation Part of: Proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors: the next chapter in CVD prevention Endothelial function Open Access ESC Congress 2017

About the speaker

Photo
Professor John Chapman

Pitie Salpetriere APHP University Hospital, Paris (France)

2 More presentations in this session

Presentation thumbnail
PCSK9 inhibitors: the story continues.
Professor J. Chapman (Paris, FR)
Slides Video
Presentation thumbnail
Challenging the data.
Professor J. Chapman (Paris, FR) Professor P. Sever (London, GB)

Access the full session

Session thumbnail
Proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors: the next chapter in CVD prevention

The Event

Event poster

ESC Congress 2017

27 August 2017 19:10 CET

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources